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Abstract
Background: It is well established that excessive consumption of a high fat diet (HFD) results in obesity; however, the
consequences of obesity on postnatal skeletal development have not been well studied.
Methodology and Principal Findings: Total enteral nutrition (TEN) was used to feed postnatal day 27 male rats
intragastrically with a high 45% fat diet (HFD) for four weeks to induce obesity. Fat mass was increased compared to rats fed
TEN diets containing 25% fat (medium fat diet, MFD) or a chow diet (low fat diet, LFD) fed ad libitum with matched body
weight gains. Serum leptin and total non-esterified fatty acids (NEFA) were elevated in HFD rats, which also had reduced
bone mass compared to LFD-fed animals. This was accompanied by decreases in bone formation, but increases in the bone
resorption. Bone marrow adiposity and expression of adipogenic genes, PPARc and aP2 were increased, whereas
osteoblastogenic markers osteocalcin and Runx2 were decreased, in bone in HFD rats compared to LFD controls. The
diversion of stromal cell differentiation in response to HFD stemmed from down-regulation of the key canonical Wnt
signaling molecule b-catenin protein and reciprocal up-regulation of nuclear PPARc expression in bone. In a set of in vitro
studies using pluripotent ST2 bone marrow mesenchymal stromal cells treated with serum from rats on the different diets
or using the free fatty acid composition of NEFA quantified in rat serum from HFD-fed animals by GC-MS, we were able to
recapitulate our in vivo findings.
Conclusions/Significance: These observations strongly suggest that increased NEFA in serum from rats made obese by
HFD-feeding impaired bone formation due to stimulation of bone marrow adipogenesis. These effects of obesity on bone in
early life may result in impaired attainment of peak bone mass and therefore increase the prevalence of osteoporosis later
on in life.
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Introduction
Although it is well established that excessive consumption of a
high fat diet (HFD) results in obesity, the consequences of obesity
on development, maturation and remodeling of the skeletal system
have not been well studied [1], [2]. Body weight (total mass
relative to height) can be a strong determinant of bone mass,
reflecting adaptation of skeletal remodeling to loading. However, if
the confounding factor of body weight is adjusted for, a strong but
inverse association between percent fat mass and bone mass is
observed [3], suggesting that body composition may be just as
important a determinant of bone quality as total body mass.
Although somewhat controversial, it has been hypothesized that
increased body fat has a negative effect on attaining peak bone
mass and bone mineral content [4], [5]. While the relationship
between obesity and bone loss and the underlying mechanisms
involved are still poorly understood, it is clear that obese children
have a significantly increased fracture risk [6] and a direct
demonstration of the effects of dietary-induced obesity on bone
loss is required.
Bone marrow surrounds trabecular elements of the skeleton and
is composed of pluripotent stromal cells. Stromal cells are
regulated by a number of factors. When osteoblast differentiation
signals, such as Runx2 and Wnt/b-catenin are activated, stromal
cells are driven into the osteoblast lineage [7]. In contrast, entry of
stromal cells into the adipocyte lineage occurs through activation
of the nuclear receptor peroxisome proliferator-activated receptor-
gamma (PPARc). Since bone and fat cells share a common origin,
a switching mechanism in mesenchymal stromal cells (MSCs) may
explain some previous observations in which factors enhance bone
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[8]. It is not known how dietary-induced obesity affects osteoblast
or adipocyte differentiation from MSCs. However, we do know
that increased adipose tissue mass leads to an increase in release of
biologically active factors, such as adipokines and free fatty acids
(FFAs), which may affect this process. Although the mechanism by
which FFAs influence the development of chronic diseases is not
clearly understood, FFAs might be a candidate to produce bone
loss [9], because decreased bone formation [10] and increased
bone resorption [11] have been shown under conditions of
hyperlipidemia. Epidemiological studies also suggest that bone
mineral density is significantly related to serum lipid profiles [12].
Bone biopsies from rodents [13] and patients [14] with
degenerative bone disorders such as osteoporosis have revealed
fat accumulation in marrow and this may be accompanied by
decreases in fatty acid (FA) unsaturation [15]. Leptin (the major
adipokine produced by fat cells) is another potential link between
obesity and bone mass. Leptin has been shown to regulate bone
mass indirectly via stimulation of bone resorption through a
neuroendocrine circuit [16]. In addition, functional leptin
receptors have recently been described in bone marrow stromal
cells and suggested to have multiple direct actions, dependent on
differentiation status [17].
In the current study, we utilized a total enteral nutrition (TEN)
rat model to feed different diets containing differing amounts of fat
during early life. We tested the hypothesis that HFD-induced
obesity may impair bone development through elevated FFA levels
by increasing bone marrow adipogenesis at the expense of
osteoblast differentiation. We show that HFD-induced obesity
favors activation of PPARc while suppressing Runx2 and b-
catenin in bone and pre-osteoblasts. The changes in differentiation
of adipocytes and osteoblasts observed in bone in vivo of these obese
animals were also demonstrated in vitro after exposing mesenchy-
mal stromal cells to serum from HFD-induced obese animals or to
an artificial mixture of purified FAs which mirrors the composition
of non-esterified free fatty acids (NEFA) appearing in serum from
HFD-induced obese rats.
Results
Body Weights, Body Fat and Bone Composition
TEN was utilized to tightly match body weight gains in all three
diet groups. However, after 4 weeks of feeding, gonadal and
retroperitoneal adipose tissue (percent body weight) differed and
was lowest in the LFD group and highest in the HFD group
(P,0.05) (Figure 1). Trabecular BMC was lower (P,0.05) in the
HFD compared to either the LFD control or MFD groups
(Figure 1E). Importantly, trabecular BMD was inversely
associated with dietary fat content and the observed retroperito-
neal and gonadal fat accumulation independent of body weight
(Figure 1F). There were no differences in total and cortical BMD
among groups (Figure 1G, H) indicating that short term HFD-
induced obesity may initially effect trabecular bone compartment,
a site of relatively high bone turnover, before eventually effecting
total and cortical BMD.
Adipogenesis in Bone
To determine if obesity affected balance between osteoblasto-
genesis and adipogenesis in the bone marrow, we measured bone
turnover markers, obesity associated factors in rat serum and
expression of key genes in bone tissue. Consistent with previously
observed enhanced osteoclastic bone resorption in obese animals
[18], we found the serum bone resorption marker RatLaps (C-
terminal telopeptide of rat type I collagen) to be greater in the
HFD-induced obese group than in the MFD or LFD groups
(P,0.05; Figure 2B). On the other hand, lower serum levels of
the specific bone formation marker osteocalcin was also found in
the HFD-induced obese animal group compared to both MFD
and LHD groups (P,0.05;Figure 2A). Serum leptin levels are
positively associated with body fat (Figure 2C). However,
increases in serum NEFA were only significant in the HFD-
induced obese animal group compared to LFD group. NEFA were
presumably derived in part from dietary lipid and in part from
hydrolysis of triglycerides in adipose tissue (Figure 2D). As can be
seen from the H&E sections depicted in Figure 3A, bone marrow
from HFD-induced obese animals had a higher accumulation of
fat than the other two groups (P,0.05). Real-time RT-PCR
analysis of mRNA levels of adipocyte-specific genes PPARc and
aP2 in bone, following aspiration of bone marrow cells, confirmed
the histological findings (Figure 3D and E). mRNA levels of
bone forming gene osteocalcin and the osteoblast differentiation
transcription factor Runx2 were inversely associated with the
amount of fat intake (Figure 3 B and C;P ,0.05).
PPARc and b-catenin
In an effort to decipher the molecular signaling involvement in
bone leading to the increased in bone marrow adiposity and
decreased bone formation in HFD-induced obese animals, we
examined the PPARc and b-catenin protein expression in bone
without bone marrow cells and bone marrow. PPARc and b-
catenin are well known adipogenic and osteoblastogenic signaling
molecules, respectively. Although we could not identify the specific
cell type, immunochemistry of b-catenin from tibial bone sections
revealed that expression of b-catenin was lower in the HFD-
induced obese animals compared to the LFD control group
(P,0.05; Figure 4A). Results from western blots of total proteins
isolated from femur, with bone marrow cells removed, confirmed
that b-catenin protein expression was significantly down-regulated
in the HFD-induced obese animals (Figure 4B). b-Catenin
protein expression was lower in the MFD group compared with
LFD controls, but was higher in this group than the HFD-induced
obese animals (P,0.05; Figure 4B). The expression of PPARc
protein in bone was opposite to b-catenin. The expression of
PPARc protein, especially nuclear fractions from bone from the
HFD-induced obese animals, was higher than in either of the
other two groups (P,0.05; Figure 4B). These data suggest that
HFD-induced obesity reciprocally regulates osteoblastogenesis and
adipogenesis.
Serum from HFD-Induced Obese Rats and an Artificial
Mixture of FAs Suppress Osteoblast Differentiation In
Vitro
We next examined the ability of serum from the HFD-induced
obese rats and of a mixture of FAs to affect osteoblast
differentiation. To do this, bone marrow derived mesenchymal
stromal ST2 cells were first treated with media containing 2%
serum from animals from each diet group for 72 h. Similar to the
in vivo data, real-time PCR revealed that b-catenin gene expression
was down-regulated by serum from the HFD-induced obese
animals compared to serum from LFD controls (P,0.05;
Figure 5A). On the other hand, PPARc gene expression was
up-regulated by HFD-induced obese rat serum (P,0.05;
Figure 5A). Similar to previous studies with macrophages [19],
we examined the effects of FAs (a 2:1 mixture of palmitate and
oleate acids) which are known to be elevated in serum of obese
individuals on ST2 cells and found a similar pattern of b-catenin
and PPARc gene expression. After 48 h treatment, b-catenin
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ner; whereas, PPARc was up-regulated by FFAs (P,0.05;
Figure 5B). Consistent with real-time data, western blot showed
an inverse association between b-catenin and PPARc. When ST2
cells were treated with FAs, down-regulated b-catenin was also
accompanied with up-regulated PPARc (P,0.05; Figure 5C).
On the other hand, when cells were treated with soluble Wnt3a, a
well known b-catenin agonist, up-regulated b-catenin was
accompanied with down-regulation of PPARc expression
(P,0.05; Figure 5C). To further examine composition and
concentration of FAs in serum NEFA from our experimental
animals, we used GC-MS after TLC separation (Figure 6A). We
found that there were 5 major FAs: palmitic, stearic, oleic, linoleic
and arachidonic acid in the ratio of 5:1:2:3:1 in rat serum and
roughly 5-fold higher concentrations in HFD-induced obese rats
with palmitate as the most prominent FA compared to either of
the other two diet groups (Figure 6B). We next tested whether the
mixture of five FAs based on the ratio and concentration of NEFA
appearing in serum from obese rats would regulate b-catenin and
PPARc in pre-osteoblasts and observed up-regulated PPARc and
concomitantly down-regulate b-catenin expression (Figure 6C,
D). The up-regulation of PPARc was also found in osteogenic
cells, such as calvarial cells isolated from neonatal rat calvaria (data
not shown here). ST2 cells were also treated with serum from rats
from each diet group or FAs in the presence of either osteogenic
(OB) medium or Wnt3a for 8 d. Both serum from the HFD-
induced obese rats and FAs suppressed bone specific alkaline
phosphatase (ALP) activity as assessed by ALP staining (P,0.05;
Figure 7A), indicating that osteoblast differentiation was
suppressed. We next explored potential mechanisms by which
HFD-induced rat serum and FAs could attenuate pro-osteogenic
canonical Wnt signaling. While both serum from HFD-fed rats
and FAs significantly increased PPARc promoter activity as
determined by a PPRE-luciferase reporter assay in C2C12 cells
(Figure 7B), b-catenin/TCF-mediated transcription was sup-
pressed (P,0.05; Figure 7B). We finally examined whether there
Figure 1. Effect of increasing dietary fat on body weight and composition in male rats. LFD, low fat diet (control pelleted AIN-93G 14% fat
diet); MFD, medium fat TEN diet (25% fat diet); HFD, high fat TEN diet (45% fat diet). (A), growth curves from three different diet groups. (B), visceral
(gonadal fat) % body weight and (C), abdominal fat % body weight (D), Representative pseudocolored images of tibial peripheral quantitative CT scans
(pQCT) (slice 3) from LFD, MFD andHFD rats. Color changes from blue, yellow, red, to gray represent decreases in bone density. Decreased bone mass in
male rats fed HFD can bevisualized.(E), totaltibialbonemineralcontent (BMC). (F), tibialtrabecularbone mineraldensity(BMD).(G),totaltibialBMD. (H),
tibial cortical BMD. Data bars are expressed as mean 6 SEM (n=6/group). Means with different letters differ significantly from each other at P,0.05,
a,b,c as determined by two-way ANOVA followed by Student-Newman-Keuls post hoc analysis for multiple pairwise comparisons.
doi:10.1371/journal.pone.0013704.g001
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PPARc in pre-osteoblasts. C2C12 cells were transfected with
siRNA against b-catenin. Silencing of b-catenin in pre-osteoblasts
increased expression of endogenous PPARc (Figure 7C), indi-
cating the possible existence of switch programs in pre-osteoblasts
that direct differentiation to either osteoblasts or adipocytes under
appropriate stimuli. Finally, we have examined whether the
increased expression of PPARc leads to increased activity and
transcriptional regulation of target genes. Sensitive TransAM
TM
transcription factor ELISA was performed and DNA binding for
activated PPARc transcription factor was analyzed using samples
from both in vivo and in vitro. As data depicted in Figure 8A,
transcriptional factor abundance was significantly increased in
bone from obese animals and in pre-osteoblasts treated with FAs
and serum from obese animals. To further detect whether FAs
enhances binding of PPARc and its target genes, ChIP assay was
carried out on the mouse aP2 gene (Figure 8B). We used an
antibody against mouse PPARc and subsequent PCR amplifica-
tion of adjacent PPRE in the enhancer of the murine aP2 (a known
target gene for PPARc) gene. We found that there was a
pronounced increase in the binding of PPARc to the aP2 enhancer
in ST2 cells treated with FAs. These data indicated that HFD-
induced obesity and FAs not only increase PPARc expression but
also its transcriptional activity.
Discussion
Bone development during the post-natal period is largely
influenced by diet intake, intrinsic hormonal milieu and physical
stimulus, although genetics or pre-natal programming may also
play an important role. Positive correlations have been observed
between body mass (weight or body mass index) and bone mineral
density, particularly at weight-bearing sites [20]. Several recently
published studies have highlighted a negative association between
obesity and either bone density or quality [21], [22], however,
none of these previous studies demonstrated a direct effect of
HFD-induced obesity on bone growth. It needs to be noted that
body composition varies widely among some populations with the
Figure 2. Effects of feeding HFD on serum leptin, non-esterified fatty acids (NEFA) and bone turnover markers. Serum bone formation
marker osteocalcin (A), resorption marker RatLaps (B), leptin levels (C), and NEFA levels (D) were measured using standard ELISA methods. Data bars
are expressed as mean 6 SEM (n=6/group). LFD, low fat diet (control pelleted AIN-93G 14% fat diet); MFD, medium fat TEN diet (25% fat diet); HFD,
high fat TEN diet (45% fat diet). Means with different letters differ significantly from each other at p,0.05, a,b,c as determined by two-way ANOVA
followed by Student-Newman-Keuls post hoc analysis for multiple pairwise comparisons.
doi:10.1371/journal.pone.0013704.g002
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differed in composition and because we could regulate the amount
of diet fed, we could infuse varied levels of total calories to establish
groups of rats which had of the same body weight, but differed
significantly in body composition to mirror this human situation.
The TEN model provides all the nutrients for rats recommended
by the National Research Council, it allows precise control of
caloric intake and manipulation of percentage of dietary fat. We
believe that using this model results in several distinct advantages
over other recent studies of obesity and bone. It not only presents a
highly reproducible and precise model to control calorie and fat
intake, but also eliminates the additional variable of differences in
weight gain. Rats fed the high fat diet (HFD) became obese (higher
percent body fat), while rats fed the low fat diet (LFD) gained the
same weight, but remained leaner. Using this animal model, we
were able to study the balance between adipocyte and osteoblast
differentiation from MSCs in bone and bone marrow in response
to obesity, independent of body weight. Our findings are
consistent with other situations such as aging, osteoporosis and
chronic alcohol abuse in which increased bone marrow adiposity
accompanies decreased bone formation and bone loss [13], [22].
Both in vivo and in vitro studies have indicated that increased NEFA
associated with HFD feeding-induced obesity may be directly
responsible for both increased marrow adipogenesis and decreased
osteoblast differentiation.
During the preparation of this manuscript, Bielohuby et al
reported that feeding a low-carbohydrate/high fat diet ad libitum
could result in significantly more visceral and bone marrow fat,
induce low BMD, and reduce bone formation in rats [24], which
are consist with our current findings. Although these investigators
showed similar changes in BMD and bone formation and
significant accumulation of fat mass, the dietary fat content was
excessive. Fat was 66% and 95% of total calories which is well
above the 30-45% commonly consumed by U.S. populations [25]
and used in the current study.
Another feature of the current study was the use of serum from
treated rats to study cells in culture. The idea is to determine if
blood born factors could be identified as bioactive components
that mediate the effects on bone observed in vivo. We have
successfully used serum from animals fed different dietary
components, such as soy protein isolate and blueberries, to treat
stromal cells in vitro in previous bone formation and resorption
studies [26], [27]. In the present report, serum from LFD control,
MFD and HFD-fed rats was used to treat ST2 or C2C12 cells, and
cell differentiation into osteoblasts was examined. While both
C2C12 and ST2 cells are derived from bone marrow, compared to
committed bipotential C2C12 cells, ST2 cells are pluripotent
mesenchymal stem/stromal cells. There were some technical
reasons for choosing these two different cells in the study, for
example transfection efficiency, however, by using these two cell
types, our results implicate the possibility that obesity has effects on
both osteoblast differentiation and commitment. Using these cell
lines treated with HFD rat serum, we were able to confirm our
hypothesis that there is an inverse relationship between differen-
tiation of adipocytes and osteoblasts within the marrow cavity
[28], and that this balance is disrupted in obesity.
Figure 3. Increased adipogenesis in bone and bone marrow in HFD-induced obese animals. (A), Represented H&E staining picture of
increased bone marrow adiposity in tibial bone section from HFD-induced obese animals (10x). (B) and (C), osteocalcin and Runx2 gene expression
measured using real-time RT-PCR. (D) and (E), PPARc and aP2 gene expression measured using real time RT-PCR. Total RNA was isolated from femur
of each animal after bone marrow aspiration for RT-PCR. LFD, low fat diet (control pelleted AIN-93G 14% fat diet); MFD, medium fat diet (25% fat diet);
HFD, high fat TEN diet (45% fat diet). Data bars are expressed as mean 6 SEM (n=6/group). Means with different letters differ significantly from each
other at p,0.05, a,b,c as determined by two-way ANOVA followed by Student-Newman-Keuls post hoc analysis for multiple pairwise comparisons.
doi:10.1371/journal.pone.0013704.g003
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at the same time diminishing osteoblast differentiation, we next
sought to determine which serum component may be the causal
factor. Although leptin may play some role in the effects of high fat
feeding in vivo [16], its main action on bone turnover is an indirect
stimulationofboneresorptionviaeffectsonRANKLexpression[16].
Direct actions of leptin on bone formation are far less clear and
appear to be related to regulation of mineralization [17]. However,
evidence has been shown that there are biologically relevant PPARc
ligands produced during adipogenesis [29]. It remains to be
determined if these endogenous PPARc ligands also inhibit
osteogenesis. We demonstrated that the concentration and ratio of
FAs appearing in serum from HFD-induced obese rats can inhibit
osteoblast differentiation. Our data indicate that NEFA appears to
reciprocally regulate PPARc and Wnt/b-catenin expression in
stromal cells at the transition level, providing a mechanistic
explanation for the association between HFD-induced obesity with
increased marrow adipogenesis and increased bone loss. Although we
have identified and characterized individual FAs in NEFA from
serum of HFD rats, whether the effects of NEFA on osteoblast and
adipocyte differentiation are due to particular single FA or synergistic
effect of multiple FAs still needs to be further investigated. It is still
Figure 4. Increased PPARc but decreased b-catenin protein expression in bone from HFD-induced obese rats. (A) Representative
pictures of immunostained tibial bone sections using an anti-mouse b-catenin polyclonal antibody. White arrows indicate immunostained b-catenin,
and black arrows indicate bone tissues. (B), Western blots of PPARc (from total protein lysates, nuclear and cytoplasmic fractions), b-catenin and b-
actin are depicted for four samples from LFD, MFD and HFD groups. LFD, low fat diet (control pelleted AIN-93G 14% fat diet); MFD, medium fat TEN
diet (25% fat diet); HFD, high fat TEN diet (45% fat diet). Proteins were isolated from long bone after aspiration of bone marrow cells.
doi:10.1371/journal.pone.0013704.g004
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does the opposite. (A), ST2 cells were treated with 2% serum from LFD, MFD or HFD rats for 3 days. Cell RNAs were isolated and real-time PCR was
performed for b-catenin and PPARc. (B), ST2 cells were treated with three different concentrations of FAs (200, 400 or 800 mM) for 24 h and 48 h. Cell
RNAs were isolated and real-time PCR was performed for b-batenin and PPARc. (C), ST2 cells were treated with a FA mixture and Wnt3a respectively
for 24 h. Cell protein lysates were collected, and western blots were performed for b-catenin, PPARc and b-actin in duplicates. Data bars are
expressed as mean 6 SEM (n=3/treatment). Means with different letters differ significantly from each other at P,0.05, a.b.c, *, P,0.05, versus
control as determined by two-way ANOVA followed by Student-Newman-Keuls post hoc analysis for multiple pairwise comparisons.
doi:10.1371/journal.pone.0013704.g005
Obesity Suppresses Bone Growth
PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13704unclear whether NEFA-induced early stage adipocyte commitment is
an event independent of osteoblast differentiation since high levels of
functional PPARc may down-regulate the amount and transcrip-
tional activity of b-catenin. Silencing of endogenous b-catenin in pre-
osteoblasts leads to over-expression of PPARc, indicating that b-
catenin acts as a suppressor of PPARc in the osteoblast differenti-
ation. However, the exact molecular mechanism responsible for the
down-regulation of b-catenin by PPARc induced by NEFA remains
to be elucidated. It is possible that there is a direct protein-protein
interaction between PPARc and b-catenin, or there is an additional
protein such as TAZ, a transcriptional coactivator with PDZ-binding
motif [30] that plays a role in mediating b-catenin down-regulation.
In summary, we have presented results demonstrating impaired
bone quality in HFD-induced obesity. This appears to be due at
least in part to serum NEFA which can directly affect stromal cell
differentiationpotentialinbonemarrow.HFD-inducedobesitymay
gradually impair the well maintained balance between adipocyte
and osteoblast differentiation in bone marrow, causing a shift that
favors adipogenesis while suppressing osteogenesis. We believe that
higher levels of NEFA in serum not only activate PPARc to
stimulate adipogenesis, but also suppress Wnt/b-catenin to inhibit
osteogenesis. Our data reveal a novel link between HFD-induced
obesity and low bone mass with profound implications for further
clinical and mechanistic research.Furthermore, these studies clearly
provide evidence to support the hypothesis that body composition
(independent of body weight) may be just as important a
determinant of bone quality as total body mass.
Materials and Methods
Animals and Diets
Time-impregnated female Sprague-Dawley rats (n=6) (Harlan
Industries, Indianapolis, IN) arrived on gestational day 4 and were
individually housed in an Association for Assessment and
Figure 6. An artificial NEFA mixture based on the ratio and concentrations of FAs appearing in serum from obese rats reciprocally
regulates b-catenin and PPARc expression in ST2 cells. (A), GC-MS analysis of NEFA. To measure NEFA composition, 100 ml of serum from LFD,
MFD or HFD rats was characterized and quantified by a Shimazu QP-2010 GC-MS system after TLC separation. (B), Mean concentrations of the 5 major
FAs in NEFA are presented. (C), ST2 cells were treated with a NEFA mixture based on individual FA concentrations appearing in serum in LFD, MFD
and HFD rats for 24 and 48 h. Real-time RT-PCR of b-catenin and PPARc mRNA expressions. (D) Western blot analysis of b-catenin and PPARc (n=3).
LFD, low fat diet (control pelleted AIN-93G 14% fat diet); MFD, medium fat TEN diet (25% fat diet); HFD, high fat TEN diet (45% fat diet). Data bars are
expressed as mean 6 SEM (n=3/treatment). *, P,0.05, versus control (vehicle treatment) as determined by t-test.
doi:10.1371/journal.pone.0013704.g006
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at the Arkansas Children’s Hospital Research Institute with
constant humidity and lights on from 06:00–18:00 hrs at 22uC. All
animal procedures were approved by the Institutional Animal
Care and Use Committee at University of Arkansas for Medical
Sciences (UAMS, Little Rock, AR). The approval ID for this study
is 2567. Pregnant rats were fed AIN-93G standard diets made with
casein as the sole protein source. Litters from these dams were
culled to 5 male and 5 female pups. Male pups at post-natal day 20
were randomly assigned (8 per group) to AIN-93G diets with or
without surgery. Experimental diets were started 7 days later
following acclimation to surgery. The control, low fat diet (LFD)
group (n=8) was fed an AIN-93G diet (14% fat) ad libitum [31].
The remaining rats were surgically implanted with an intragastric
cannula and fed by TEN as described previously [32–34]. Liquid
diets were formulated to contain the nutrients recommended by
the National Research Council. Rats were randomly assigned to
either high fat (HFD; n=8) or medium fat TEN diets (MFD;
n=8). The HFD diet contained 25% protein, 45% fat (corn oil),
and 30% carbohydrate and the MFD diet contained 25% protein,
25% fat (corn oil), and 50% carbohydrate. Body weights were
monitored daily and the infusion rate of TEN diets adjusted daily
in order to match the weight gain of TEN rats to that of the ad
libitum-fed LFD control group. The average amount of diet
consumed by TEN animals was 352 Kcal per kilogram of body
weight, and by control animals was 346 Kcal per kilogram of body
weight. Rats were infused TEN diets from 6 PM to 8 AM (lights off
7 PM to 7 AM) for 4 weeks. At the completion of the experiment,
rats were anesthetized by injection with 100 mg Nembutal/kg
body weight (Avent Laboratories), followed by decapitation, and
serum, left and right tibia, femur, and gonadal and abdominal fat
were collected.
Bone Analysis
Peripheral quantitative computerized tomography (pQCT) was
performed on formalin fixed left tibia for bone mineral density
measurement using a method well established previously in our lab
[32] using a STRATEC XCT 960 M unit (XCT Research SA,
Figure 7. Serum from HFD-induced obese rats and an artificial FA mixture suppress osteoblast differentiation. (A), ST2 cells were
cultured in 12 well plates. Cells were treated with 2% serum from LFD, MFD or HFD rats, 50 ng/ml Wnt3a, 400 mM FAs and their combination for 7
days in the presence or absence of osteogenic medium. Alkaline phophatase staining was performed. (B), 2% serum from HFD-induced obese rats
and an artificial FA mixture significantly decreased TCF/LEF-dependent transcription of a luciferase reporter gene (TOPFLASH) in C2C12 osteoblastic
cells compared with cells treated with LFD serum. Luciferase activity in C2C12 cells transfected with a PPRE-luc reporter construct and treated with
2% serum from LFD, MFD or HFD-fed rats, 50 ng/ml Wnt3a, 400 mM FAs and their combination for 24 h. (C), b-catenin gene was knock down using b-
catenin siRNA in ST2 cells. After 24 h of b-catenin siRNA, cell proteins were collected and western blot was performed for b-catenin and PPARc. Bars
are expressed as mean 6 SEM in triplicates. *, P,0.05, versus control by ANOVA followed by Student-Newman-Keuls post hoc analysis for multiple
pairwise comparisons.
doi:10.1371/journal.pone.0013704.g007
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PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13704Norland Medical Systems, Fort Atkins, WI) specifically configured
for small bone specimens. Software version 5.4 was used with
thresholdsof 570 mg/cm
3 to distinguishcortical bone and 214 mg/
cm
3 to distinguish trabecular from cortical and sub-cortical bone.
Tibial bone mineral density (BMD) and bone mineral content
(BMC) were automatically calculated and color images generated.
The CVs for these measurements were ,2%. The position for
pQCT scanning was defined at a distance from the proximal tibia
growth palate corresponding to ,7% of the total length of the tibia.
Distance between each scanningwas 1 mm, total of 5 scans (5 slices)
were carried out. Data were expressed as the mean of three
contiguous slices with the greatest trabecular bone density.
Serum Bone Remodeling Markers, Leptin and NEFA
The serum bone formation markerosteocalcin and theserumbone
resorption marker procollagen cross-links RatLaps were measured by
Rat-MID
TM osteocalcin ELISA and RatLapsTM ELISA, respec-
t i v e l y ,f r o mN o r d i cB i o s c i e n c e sD i a g n o s t i c( H e r l e v ,D e n m a r k ) .
Serum levels of Leptin (ALPCO Diagnostics, 26 Keewaydin Drive
Unit G. Salem, NH) and total non-esterified fatty acids (NEFA)
(Wako Diagnostics, Wako Chemicals USA, Inc. VA, USA) were
measured using standard ELISA method according to procedures
provided from the manufacturer. NEFA composition in serum from
HFD and LFD-fed rats was characterized and quantified using a
Shimazu QP-2010 GC-MS after TLC separation.
Bone Histology and Immunofluorescence
H&E staining and immunostaining for b-catenin on decalcified
tibia sections were carried out using standard protocol from
VectaStain ABC kit (Vector Laboratory, Burlingame, CA, USA).
For b-catenin immunostaining, sections were deparaffinized,
blocked with normal goat serum in 2% BSA-PBS for 30 min,
and incubated with polyclonal antibody to b-catenin for 60 min.
After three washes with PBS, sections were incubated with
biotinylated secondary antibody, which was labeled with strepta-
vidin-conjugated Alexa 488 (Molecular Probes, Carisbad, CA,
USA) and counterstained with DAPI (Molecular Probes, Carisbad,
CA, USA) [35].
RNA Isolation and Real-Time PCR Array
Rat femur bone was harvested followed by removal of marrow
cells by aspiration according to methods previously described [36].
RNA from femur tissue were extracted using TRI Reagent (MRC
Inc., Cincinnati, OH) according to the manufacturer’s recom-
mendation followed by DNase digestion and column cleanup
using QIAGEN mini columns [36]. Reverse transcription was
carried out using an iScript cDNA synthesis kit from Bio-Rad
(Hercules, CA). RNA isolation from in vitro cell culture was also
described previously [35]. All primers for real-time PCR analysis
used in this report were designed using Primer Express software
2.0.0 (Applied Biosystems), and are listed in Table 1.
Cell Culture
Bone marrow stromal cell line ST2 cells or C2C12 cells were
cultured in a-MEM supplemented with 10% fetal bovine serum
(FBS) (Hyclone, Logan, UT), penicillin (100 Units/ml), strepto-
mycin (100 mg/ml), and glutamine (4 mM). ST2 cells in 24- and 6-
well plates were treated in the presence or absence of 50 ng/ml of
soluble Wnt 3a (R & D Systems, Inc.) in combination with or
without 400 mM fatty acids (FAs, oleate and palmitate 1:2 mixture,
Sigma-Aldrich) for 7 days followed by ALP staining and collection
of proteins for western blotting according to previously published
methods [36]. FAs were dissolved in 95% ethanol at 60uC and
then mixed with pre-warmed BSA (10%) to yield a stock
concentration of 8 mM. Cells were also treated with a second
mixture of FAs, the composition, ratio and concentration of which
was based on the composition of NEFA appearing in serum from
HFD-fed rats. MEM (Invitrogen, Carlsbad, CA) supplemented
with 10% FBS, 1 mM ascorbyl-2-phosphate (Sigma-Aldrich), and
4 mM L-glutamine was used as osteoblast differentiation (OB)
medium while MEM supplemented with 10% FBS was used as
without OB medium. ST2 cells were also treated with cell culture
Figure 8. Activation of PPARc and regulation of its target gene. (A), nuclear proteins were extracted from rat tibia and from ST2 cells treated
with rat serum and FAs mixture using 10 cm dish. TransAM was performed for activity of PPARc. (B) ST2 cells were treated for 24 h with FAs mixture
according to the concentrations that appeared in animal circulation. ChIP of mouse aP2 enhancer elements by specific anti PPARc antibody. Control,
normal cell culture medium; LFD, low fat diet (control pelleted AIN-93G 14% fat diet); MFD, medium fat TEN diet (25% fat diet); HFD, high fat TEN diet
(45% fat diet). Bars are expressed as mean 6 SEM in triplicates. *, P,0.05, versus LFD by ANOVA followed by Student-Newman-Keuls post hoc analysis
for multiple pairwise comparisons. #,P ,0.05, versus control by t-test.
doi:10.1371/journal.pone.0013704.g008
Table 1. Real-Time Reverse-Transcription Polymerase Chain Reaction (RT-PCR) Primer Sequences.
Gene Forward Primer Reverse Primer
Rat
Osteocalcin AAGCCCAGCGACTCTGAGTCT GCTCCAAGTCCATTGTTGAGGTA
RUNX2 CCGTGGCCTTCAAGGTTGTA ATTTCGTAGCTCGGCAGAGTAGTT
PPARc CCAAGTGACTCTGCTCAAGTATGG GTCATGAATCCTTGTCCCTCTGA
aP2 CCAAGCCCAACTTGATCATCAG TGGTCGACTTTCCATCCCACT
GAPDH TGAGGTGACCGCATCTTCTTG TGGTAACCAGGCGTCCGATA
Mouse
PPARc GCTTCCACTATGGAGTTCATGCT CCGGCAGTTAAGATCACACCTAT
b-Catenin GATATTGACGGGCAGTATGCAA AACTGCGTGGATGGGATCTG
GAPDH GTATGACTCCACTCACGGCAAA GGTCTCGCTCCTGGAAGATG
doi:10.1371/journal.pone.0013704.t001
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culture medium was changed every 2 d.
Constructs for Luciferase Assay and siRNA
Luciferase reporter constructs were introduced into C2C12 cells
by transient transfection using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA). PPRE-luciferase (PPRE-luc) expression
plasmids were kindly provided by B. Spiegelman, Harvard
Medical School, Boston, MA (Addgene plasmid 1015). TCF/
LEF-Firefly luciferase reporter plasmid (TOPFLASH) and control
reporter containing mutant TCF binding sites (FOPFLASH) were
purchased from Upstate Biotechnology. C2C12 cells were plated
in 48 well plates and transfected 24 h later with a total of 0.4 mgo f
DNA. Luciferase activity assays were performed as previously
described [34]. b-catenin siRNA was purchased from Santa Cruz
Biotechnology, Inc. (sc-44253) and transfection of b-catenin
siRNA into C2C12 cells was performed following instruction
provided by manufacturer.
Western Blotting, TransAM
TM and ChIP Assay
Right tibia bone tissue proteins and in vitro cellular proteins were
extracted using a cell lysate buffer described previously [35], [36].
Briefly, after cleaning of surrounding connective tissues and
aspiration of bone marrow cells, right tibia was smashed to small
pieces using surgical pliers. After adding about 400 ml of cell lysate
buffer, bone tissues were homogenized using a tissue homogenizer.
Nuclear and cytoplasmic protein extractions were performed using
NE-PER Nuclear and Cytoplasmic Extraction Reagents kit
purchased from PIERCE (cat# 78833, PIERCE Biotechnology).
b-catenin, PPARc and b-actin in bone tissue and in vitro osteoblasts
were assessed by Western immunoblotting using goat polyclonal
antibody recognizing b-catenin (Cell Signaling), rabbit polyclonal
antibody recognizing PPARc (Cell Signaling) and mouse poly-
clonal antibody recognizing b-actin (Sigma) followed by incuba-
tion with either an anti- rabbit or an anti-mouse antibody
conjugated with horseradish peroxidase (Santa Cruz). SuperSignal
West Pico chemiluminescent substrate (Pierce) was used for
developing blots. Quantitation of the intensity of the bands in
the autoradiograms was performed using a ChemiDoc XRS
imaging system (Bio-Rad). TransAM
TM PPARc transcription
factor ELISA kits were purchased from Active Motif (Actove Motif
North America, Carlsbad, California, USA. Cat#40196). Nuclear
protein fractions from both tissue and cell samples were used for
TransAM assay. The assay was performed according to proce-
dures provided from the manufacturer. ChIP assay was performed
basically as described in the protocol of the ChIP assay kit from
Active Motif (Cat# 53008&53009). FAs treated ST2 cells were
cross-linked with formaldehyde in PBS for 10 min, lysed in lysis
buffer provided in the kit. 50 ml of chromatin was incubated with
anti-PPARc antibody from Santa Cruz (sc-7196x). Recovered
immunoprecipitates were used as template for PCR of aP2 gene
using the following mouse specific primers: aP2-F, CCTCCA-
CAATGAGGCAAATC; aP2-R, CTGAAGTCCAGATAGCTC.
Statistical Analyses
Data were expressed as means 6 standard error. One-way or
two way analysis of variance (ANOVA) followed by Student-
Newman-Keuls post hoc analysis was used to compare the
treatment groups. Values were considered statistically significant at
p,0.05.
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